Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias

BACKGROUND: Increasing evidence supports the use of plasma biomarkers of neurodegeneration and neuroinflammation to screen and diagnose patients with dementia. However, confirmatory studies are required to demonstrate their usefulness in the clinical setting. METHODS: We evaluated plasma and cerebro...

Descripción completa

Detalles Bibliográficos
Autores principales: Baiardi, Simone, Quadalti, Corinne, Mammana, Angela, Dellavalle, Sofia, Zenesini, Corrado, Sambati, Luisa, Pantieri, Roberta, Polischi, Barbara, Romano, Luciano, Suffritti, Matteo, Bentivenga, Giuseppe Mario, Randi, Vanda, Stanzani-Maserati, Michelangelo, Capellari, Sabina, Parchi, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555092/
https://www.ncbi.nlm.nih.gov/pubmed/36221099
http://dx.doi.org/10.1186/s13195-022-01093-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555092/
https://www.ncbi.nlm.nih.gov/pubmed/36221099
http://dx.doi.org/10.1186/s13195-022-01093-6

Ejemplares similares